BackFlexion Therapeutics Overview

Flexion Therapeutics Net Income

Profitability analysis for FLXN.

Quarterly Net Income

-$30.31M
↓ 23.03% YoY

As of Sep 2021

Annual Net Income (TTM)

-$100.72M
↑ 21.05% YoY

Trailing 12 months ending Sep 2021

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin